COVID-19: Unraveling The Details Behind The Numbers
Source: Trialbee AB
As of April 24th, there were 3.1M COVID-19 cases worldwide, with over 219K deaths.
Along with better testing, the race for a cure is on with vaccines, prophylactics/antibodies and therapies in clinical trials. Governments, academic institutions and biopharma sponsors worldwide have committed significant resources to defeating the virus.
The war against COVID-19 is on.
According to Clinicaltrials.gov, 1057 COVID-19 trials are listed seeking to enroll ~1M patients (not including the WHO Trial registry). The graphs below illustrate trial distribution by geography, sponsor, status and phase.
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
Trialbee AB
This website uses cookies to ensure you get the best experience on our website. Learn more